FIELD: medicine.
SUBSTANCE: inventions relate to medicine, in particular to psychiatry and can be used for treatment or prevention of anxiety state or anxiety state episode. Pharmaceutical composition includes efficient amount of ELB 139 (1-(4-chlorphenyl)-4-pyperidinoimidazolin-2-on) or 1-(4-methoxyphenyl)-4-pyperidinoimidazolin-2-on, and method includes introduction to patient of efficient amount of ELB 139 (1-(4-chlorphenyl)-4-pyperidinoimidazolin-2-one) or 1-(4-methoxyphenyl)-4-pyperidino imidazolin-2-one.
EFFECT: introduction of ELB 139 (1-(4-chlorphenyl)-4-pyperidinoimidazolin-2-one) or 1-(4-methoxyphenyl)-4-pyperidinoimidazolin-2-one for treatment or prevention of anxiety state or anxiety state episode has stronger effect in comparison with other compounds of similar chemical formula.
8 cl, 7 ex, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATMENT OF BRAIN ISCHEMIC INJURY | 2004 |
|
RU2288714C2 |
| METHOD OF RELIEVING ALCOHOL ABSTINENCE SYNDROME BY BLOCKADE OF BENZODIAZEPINE RECEPTORS | 2011 |
|
RU2468799C1 |
| APPLICATION OF ACTIVE PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES | 2011 |
|
RU2563167C2 |
| METHODS FOR IMPROVEMENT OF MEMORY AND COGNITIVE FUNCTION AND TREATMENT OF MEMORY DISORDERS AND COGNITIVE DISORDERS | 2018 |
|
RU2785125C2 |
| TREATING PSYCHOLOGICAL CONDITIONS WITH USING M-MUSCARINIC ANTAGONISTS | 2007 |
|
RU2477634C2 |
| 11-(4-TERT-BUTYLBENZYL)-2,3,4,5-TETRAHYDRO[1,3]DYAZEPINO[1,2-A]BENZIMIDAZOLE HYDROBROMIDE WITH ANXIOLYTIC AND ANTICONVULSANT ACTIVITY | 2017 |
|
RU2662242C1 |
| SELECTIVE INVERSE SEROTONIN 2A/2C RECEPTOR AGONISTS APPLICABLES AS THERAPEUTIC AGENTS FOR NEURODEGENERATIVE DISORDERS | 2008 |
|
RU2465267C2 |
| AGENT FOR MANAGING ALCOHOL ABSTINENCE SYNDROME | 2012 |
|
RU2521226C2 |
| CYCLOPROPYLPIPERIDINE GLYCINE TRANSPORTER INHIBITORS | 2005 |
|
RU2387644C2 |
| SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS, USED AS THERAPEUTICS FOR NEURODEGENERATIVES DISEASES | 2004 |
|
RU2332401C2 |
